These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 26817006)

  • 1. Value of serum 1,5-anhydroglucitol measurements in childhood obesity in the continuum of diabetes.
    Yoo HY; Kwak BO; Son JS; Kim KS; Chung S
    Ann Pediatr Endocrinol Metab; 2015 Dec; 20(4):192-7. PubMed ID: 26817006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of glycemic control markers - 1,5 anhydroglucitol, fructosamine, and glycated hemoglobin among Asian Indians with different degrees of glucose intolerance.
    Pramodkumar TA; Jayashri R; Gokulakrishnan K; Velmurugan K; Pradeepa R; Anjana RM; Mohan V
    Indian J Endocrinol Metab; 2016; 20(5):690-695. PubMed ID: 27730082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum 1,5-anhydroglucitol level as a screening tool for diabetes mellitus in a community-based population at high risk of diabetes.
    Wang Y; Yuan Y; Zhang Y; Lei C; Zhou Y; He J; Sun Z
    Acta Diabetol; 2017 May; 54(5):425-431. PubMed ID: 27896445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of 1.5-anhydroglucitol for monitoring glycemic control in islet transplant recipients.
    Peixoto EM; Bozkurt NC; Messinger S; García MI; Lauriola V; Corrales A; Herrada E; Ricordi C; Alejandro R
    Cell Transplant; 2014; 23(10):1213-9. PubMed ID: 23803279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1,5-anhydroglucitol as a useful marker for assessing short-term glycemic excursions in type 1 diabetes.
    Seok H; Huh JH; Kim HM; Lee BW; Kang ES; Lee HC; Cha BS
    Diabetes Metab J; 2015 Apr; 39(2):164-70. PubMed ID: 25922811
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol.
    Lee JE
    Ann Pediatr Endocrinol Metab; 2015 Jun; 20(2):74-8. PubMed ID: 26191510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dispersion of serum 1,5 anhydroglucitol values in patients with type 2 diabetes at goal of HbA1c.
    Villena Chávez JE; Neira Sánchez ER; Poletti Ferrara LF
    Diabetes Res Clin Pract; 2023 May; 199():110668. PubMed ID: 37061006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum 1,5-Anhydroglucitol Concentrations Remain Valid as a Glycemic Control Marker In Diabetes with Earlier Chronic Kidney Disease Stages.
    Bai Y; Yang R; Song Y; Wang Y
    Exp Clin Endocrinol Diabetes; 2019 Apr; 127(4):220-225. PubMed ID: 29270924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin Resistance in Type 1 Diabetes Mellitus and Its Association with Patient's Micro- and Macrovascular Complications, Sex Hormones, and Other Clinical Data.
    Šimonienė D; Platūkiene A; Prakapienė E; Radzevičienė L; Veličkiene D
    Diabetes Ther; 2020 Jan; 11(1):161-174. PubMed ID: 31792784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of plasma glucose fluctuation with a combination test of hemoglobin A1c and 1,5-anhydroglucitol.
    Yamanouchi T; Moromizato H; Shinohara T; Minoda S; Miyashita H; Akaoka I
    Metabolism; 1992 Aug; 41(8):862-7. PubMed ID: 1640864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating 1,5-Anhydroglucitol as a Biomarker of ß-cell Mass Independent of a Diabetes Phenotype in Human Subjects.
    Jiménez-Sánchez C; Mezza T; Sinturel F; Li L; Di Giuseppe G; Quero G; Jornayvaz FR; Guessous I; Dibner C; Schrauwen P; Alfieri S; Giaccari A; Maechler P
    J Clin Endocrinol Metab; 2022 Sep; 107(10):2833-2843. PubMed ID: 35867405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rational diagnoses of diabetes: the comparison of 1,5-anhydroglucitol with other glycemic markers.
    Malkan UY; Gunes G; Corakci A
    Springerplus; 2015; 4():587. PubMed ID: 26543722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,5-anhydroglucitol is a good predictor for the treatment effect of the Sodium-Glucose cotransporter 2 inhibitor in Japanese patients with type 2 diabetes mellitus.
    Usui M; Tanaka M; Takahashi H
    J Clin Transl Endocrinol; 2020 Sep; 21():100233. PubMed ID: 32904185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,5-Anhydroglucitol reflects postprandial hyperglycemia and a decreased insulinogenic index, even in subjects with prediabetes and well-controlled type 2 diabetes.
    Won JC; Park CY; Park HS; Kim JH; Choi ES; Rhee EJ; Lee WY; Oh KW; Kim SW; Park SW
    Diabetes Res Clin Pract; 2009 Apr; 84(1):51-7. PubMed ID: 19187997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting long-term glycemic control of post-educational type II diabetic patients by evaluating serum 1,5-anhydroglucitol levels.
    Sone H; Okuda Y; Yamaoka T; Kawakami Y; Odawara M; Matsushima T; Kawai K; Yamashita K
    Diabetes Res Clin Pract; 1996 Oct; 34(2):83-8. PubMed ID: 9031810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Finding the clinical utility of 1,5-anhydroglucitol among primary care practitioners.
    Peabody J; Paculdo D; Acelajado MC; Burgon T; Dahlen JR
    J Clin Transl Endocrinol; 2020 Jun; 20():100224. PubMed ID: 32368501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation between Glycated Hemoglobin and Triglyceride Level in Type 2 Diabetes Mellitus.
    Naqvi S; Naveed S; Ali Z; Ahmad SM; Asadullah Khan R; Raj H; Shariff S; Rupareliya C; Zahra F; Khan S
    Cureus; 2017 Jun; 9(6):e1347. PubMed ID: 28713663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity Does Not Modulate the Glycometabolic Benefit of Insoluble Cereal Fibre in Subjects with Prediabetes-A Stratified Post Hoc Analysis of the Optimal Fibre Trial (OptiFiT).
    Kabisch S; Meyer NMT; Honsek C; Gerbracht C; Dambeck U; Kemper M; Osterhoff MA; Birkenfeld AL; Arafat AM; Weickert MO; Pfeiffer AFH
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31717901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid-Acting Insulin Analogues Versus Regular Human Insulin: A Meta-Analysis of Effects on Glycemic Control in Patients with Diabetes.
    Nicolucci A; Ceriello A; Di Bartolo P; Corcos A; Orsini Federici M
    Diabetes Ther; 2020 Mar; 11(3):573-584. PubMed ID: 31873857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycated hemoglobin for the diagnosis of diabetes and prediabetes: Diagnostic impact on obese and lean subjects, and phenotypic characterization.
    Incani M; Sentinelli F; Perra L; Pani MG; Porcu M; Lenzi A; Cavallo MG; Cossu E; Leonetti F; Baroni MG
    J Diabetes Investig; 2015 Jan; 6(1):44-50. PubMed ID: 25621132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.